Drug Czar's Latest B.S. Claim: Pot Makes Teens Crazy and Suicidal

By Paul Armentano, NORML. Posted May 13, 2008.

Editor's note: NORML deputy director Paul Armentano catches the latest insanity from the drug czar.

Feds: Teen use of pot can lead to mental illness
via The Associated Press

WASHINGTON (AP) -- Depression, teens and marijuana are a dangerous mix that can lead to dependency, mental illness or suicidal thoughts, according to a White House report released Friday.

A teen who has been depressed at some point in the past year is more than twice as likely to have used marijuana as teens who have not reported being depressed -- 25 percent compared with 12 percent, said the report by the White House Office of National Drug Control Policy.

“Marijuana is a more consequential substance of abuse than our culture has treated it in the last 20 years,” said John Walters, director of the office. “This is not just youthful experimentation that they’ll get over as we used to think in the past.”

…

“It’s not something you look the other way about when your teen starts appearing careless about their grooming, withdrawing from the family, losing interest in daily activities,” Walters said. “Find out what’s wrong.”

Pot Smoking Won’t Make You Crazy, But Dealing With The Lies About It Will
via Alternet


Perhaps the most impressive evidence against the cause-and-effect relationship concerns the unvarying rate of psychoses across different eras and different countries. People are no more likely to be psychotic in Canada or the United States (two nations where large percentages of citizens use cannabis) than they are in Sweden or Japan (where self-reported marijuana use is extremely low). Even after the enormous popularity of cannabis in the 1960s and 1970s, rates of psychotic disorders haven’t increased.

There is limited data suggesting an association, albiet a minor one, between chronic cannabis (primarily among adolescents and/or those predisposed to mental illness) and increased symptoms of depression, psychotic symptoms, and/or schizophrenia. However, interpretation of this data is troublesome and, to date, this observation association is not well understood. Identified as well as unidentified confounding factors (such as poverty, family history, polydrug use, etc.) make it difficult, if not impossible, for researchers to adequately determine whether any cause-and-effect relationship exists between cannabis use and mental illness. Also, many experts point out that this association may be due to patients’ self-medicating with cannabis, as survey data and anecdotal reports of individuals finding therapeutic relief from both clinical depression and schizotypal behavior are common within medical lore, and clinical testing on the use of cannabinoids to treat certain symptoms of mental illness has been recommended.

If there does exist a minority population of citizens who may be genetically prone to potential harms from cannabis (such as, possibly, those predisposed to schizophrenia), then a regulated system would best identify and educate this sub-population to pot’s potential risks so that they may refrain from its use, if they so choose.

To draw a real world comparison, millions of Americans safely use ibuprofen as an effective pain reliever. However, among a minority of the population who suffer from liver and kidney problems, ibuprofen presents a legitimate and substantial health risk. However, this fact no more calls for the criminalization of ibuprofen among adults than do these latest allegations, even if true, call for the current prohibition of cannabis.

See more stories tagged with: marijuana, drug czar

Paul Armentano is the senior policy analyst for the NORML Foundation in Washington, DC.

Liked this story? Get top stories in your inbox each week from DrugReporter! Sign up now »